Pharmaceutical Executive February 29, 2024
Mike Hollan

The agency teamed up with the software company to develop platforms and networks to collect de-identified data.

FDA previously teamed up with Workflow Services to build out a program to collect de-identified data. Now, 100 days into the partnership, Workflow Services is releasing data that shows it has hit a milestone.

During this time period, Workflow Services says that it has increased the number of users on its platform, built partnerships with both industry trade organizations and test manufacturers, and built up its team, according to a press release.1 Earlier this year, Workflow Services expanded its leadership team to better serve the goals of its partnership with FDA.

In a press release, Workflow Services CEO Kevin Houlihan said, “The retail...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Health IT, Partnerships, Technology, Trends
Related Articles:
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
FDA Approves Third Tocilizumab Biosimilar
The Biden Administration’s Swan Song on Digital Health: Two FDA Guidances on Artificial Intelligence and FDA’s Defense of its Clinical Decision Support Guidance
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown

Share This Article